Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal...

Area of Science:

• Molecular biology
• Immunology
• Oncology

Background:

• CD44 is a cell surface glycoprotein with multiple alternatively spliced isoforms.
• The hematopoietic isoform (CD44H) is crucial for lymphocyte homing.
• Aberrant CD44 variant expression is implicated in epithelial carcinoma metastasis.

Purpose of the Study:

• To investigate CD44 transcript variants in large-cell lymphomas (LCLs) compared to normal B cells and epithelial cells.
• To determine if specific CD44 isoforms correlate with lymphoma stage or location.
• To understand the role of CD44 variant expression in lymphoid and epithelial malignancy trafficking.

Main Methods:

• Semiquantitative RNA-based polymerase chain reaction (PCR) was used to analyze CD44 mRNA.
• Specific CD44 variants were identified by size, exon-specific probes, and sequence analysis.
• Samples included primary nodal, extranodal, and disseminated LCLs, normal Ig-activated splenic B cells, and epithelial cells.

Main Results:

• Extranodal and disseminated LCLs exhibited increased CD44H and novel exon 10-containing isoforms compared to nodal LCLs.
• CD44 transcripts in advanced LCLs resembled those in normal activated B cells.
• Epithelial malignancies showed reduced CD44H and increased larger CD44 variants.

Conclusions:

• Specific CD44 splicing variants are differentially expressed in LCLs, correlating with disease dissemination.
• The CD44 expression profile in advanced LCLs mirrors that of activated B cells, suggesting a role in immune cell-like trafficking.
• Regulated CD44 variant expression likely influences the migration and spread of both lymphoid and epithelial malignancies.